Stopping Nolvadex (Tamoxifen) After 5 Years: What Happens to Side Effects? (2026)

If you stop taking a hormone therapy drug like tamoxifen (Nolvadex) after five years, the menopause-like symptoms experienced during treatment tend to gradually ease, but changes caused by reduced bone density or premature ovarian insufficiency may still require ongoing management after discontinuation. The specific timing of discontinuation and any additional tests should be discussed with your care team.

Key Takeaways

• For hormone receptor-positive breast cancer, it is common practice to continue oral hormone therapy for 5 to 10 years after surgery.
• During hormone therapy, menopause-like symptoms such as hot flashes, joint stiffness, and vaginal dryness may occur, along with reduced bone density, which is why bone scans are typically done alongside treatment.
• Treatment-related premature ovarian insufficiency can present as irregular or absent menstruation, hot flashes and night sweats, vaginal dryness, mood changes, joint and muscle pain, and sleep disturbances, and may carry long-term risks of osteoporosis and cardiovascular issues (U.S. National Cancer Institute, NCI).
• Late effects may include not only bone loss but also cardiac or pulmonary problems and thyroid abnormalities; it is recommended to discuss with your care team which tests are needed based on the treatment you received (NCI).
• Whether and when to stop medication depends on individual subtype, recurrence risk, and menopausal status, so this decision must always be made in consultation with your care team.

What Changes Happen in the Body After Finishing Tamoxifen?

• Stopping the medication does not mean all changes experienced during treatment disappear immediately. Hormone therapy is accompanied by menopause-like symptoms (hot flashes, joint stiffness, vaginal dryness), and these symptoms are often managed over a period of several years.
• Treatment-induced premature ovarian insufficiency can present as irregular or absent menstruation, hot flashes and night sweats, vaginal dryness, mood changes, joint and muscle pain, and sleep disturbances, and in the long term may lead to osteoporosis and cardiovascular risk (NCI).
• Reduced bone density is a representative change that can occur during hormone therapy, and it is recommended to manage this alongside regular bone scans. Bone status may need continued monitoring even after discontinuation.

Symptoms That May Persist After Discontinuation and How to Manage Them

• Step 1 — Pre-discontinuation assessment: Review your bone density, gynecologic status, and current symptoms up to that point.
• Step 2 — Symptom monitoring: Observe over several months whether symptoms such as hot flashes, sleep disturbances, and joint pain are decreasing.
• Step 3 — Bone density and cardiovascular management: Osteoporosis and cardiovascular risk are items that need long-term attention even after treatment ends.
• Step 4 — Consult your care team: If symptoms persist or new changes appear, the starting point is to inform your care team rather than endure them.

FAQ — Do Menopausal Symptoms Disappear Immediately After Stopping Tamoxifen?

It is difficult to say they disappear immediately. Symptoms related to treatment-induced premature ovarian insufficiency (hot flashes, night sweats, vaginal dryness, mood changes, joint and muscle pain, sleep disturbances) may persist for some time even after treatment ends (NCI). Since the pace at which symptoms ease varies significantly between individuals, it is best to review your progress together with your care team.

FAQ — Do I Still Need Bone Scans After Discontinuation?

Reduced bone density that develops during hormone therapy, along with the resulting long-term risks of osteoporosis and cardiovascular disease, may need to continue being managed even after treatment ends. It is recommended to discuss with your care team which tests are necessary based on the treatment you received (NCI).

Sources and Notes

This article was written based on breast cancer notes and long-term side effect management notes (including materials from the U.S. National Cancer Institute, NCI). This content is intended for general medical information purposes only, and diagnosis, treatment methods, and outcomes may vary depending on individual circumstances. Accurate diagnosis and treatment must always be determined through consultation with your care team.